Nausea in Medical Technology
Navigation Links
Nausea in Medical Technology
... hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%), and musculoskeletal ... (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting ... in the seven MDS/MPD patients assessed were nausea (57%); diarrhea and muscle cramps (43% each); ...
... experience gastrointestinal side effects, such as nausea and vomiting. The use of opioid pain medicines ... risk factor for experiencing these side effects. nausea and vomiting are uncomfortable and bothersome and ... orthopedic surgery and significant reduction in nausea and/or vomiting compared to oxycodone IR. ...
... asthenia (40% vs 51%), fever (21% vs 31%), nausea (46% vs 63%), stomatitis (41% vs 15%), ... (31% vs 22%), asthenia (22% vs 18%), nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting ... (<150,000 platelets/mm3, 61%), nausea (18%), asthenia (7%), fever (8%), alopecia ...
... (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting ... (>10%) were rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), ... 4 mg (n=1031) were as follows: bone pain (55%), nausea (46%), fatigue (39%), anemia (33%), pyrexia ...
... vs. 11 percent in the lopinavir/r arm. nausea was reported in two percent vs. three percent, ... headache (5 percent), abdominal pain (4 percent), nausea (3 percent), vomiting (2 percent), and rash (2 ... (> or = Grade 2) were diarrhea (12 percent), nausea (7 percent), abdominal pain (5 percent), rash (6 ...
... hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%) and musculoskeletal ... (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting ... (20.5%) and peripheral edema was not reported. nausea and vomiting were the most commonly reported ...
... no serious adverse events reported. Drug-induced nausea was very low and migraine-associated nausea also decreased with treatment. The Company ... of intravenous DHE while avoiding the nausea that intravenous administration can cause. ...
... Benefits for Patients with Chemotherapy-Induced nausea and Vomiting PHILADELPHIA and LONDON, May 29 ... of patients experiencing chemotherapy-induced nausea and vomiting (CINV). Adding a single oral dose ... CINV can last for about five days and the risk of nausea and vomiting without prophylaxis is greater than ...
... of nausea. Patients who experience severe nausea should inform their physician. AMITIZA should ... common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal ... common adverse reactions (incidence > 4%) were nausea (8%), diarrhea (7%), and abdominal pain (5%). ...
... 3%), fatigue (ABILIFY: 11%; placebo: 4%), nausea (ABILIFY: 11%; placebo: 4%), akathisia (ABILIFY: ... disorder (20% vs 3%), fatigue (11% vs 4%), nausea (11% vs 4%), akathisia (10% vs 2%), blurred ... with agitation associated with bipolar mania: nausea (9% vs 3%) Please see FULL PRESCRIBING ...
... diarrhea (14 percent vs. 24 percent), and nausea (15 percent vs. 15 percent). In DUET-2, the ... of any type (16.6 percent vs. 11.1 percent) and nausea (14.6 percent vs. 10.8 percent). Important ... were rash (16.9 percent vs. 9.3 percent) and nausea (13.9 percent vs. 11.1 percent) -- The most ...
... mmHg for those with abnormal baselines]. Safety Profile nausea was the most common event during the 30-week treatment period and ... vomiting, diarrhea, dizziness, headache, feeling jittery and acid stomach. nausea is the most common side effect when first starting BYETTA, but decreases ...
... common adverse events in the pirfenidone group as compared to placebo were nausea (35% vs. 18% in CAPACITY 2 and 38% vs. 16% in CAPACITY 1), rash (31% vs. ... to various adverse events were as follows: IPF (2.9/2.6); rash (1.4/0); nausea (1.4/0); bladder cancer (0.9/0); photosensitivity reaction (0.9/0.3); ...
... 80% of patients completed the study, and there was one withdrawal due to nausea in each treatment arm. There was no major hypoglycemia in any treatment ... adverse events among exenatide once weekly and sitagliptin users were nausea and diarrhea. Upper respiratory tract infection and peripheral edema were ...
... were asthenic conditions (including fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC ... were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), ...
... reported adverse reactions (>10%) were rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), ... reported adverse reactions (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting (23%-58%), diarrhea ...
... the stable-dose treatment period of the placebo-controlled trial included nausea (37% vs. 21% placebo), constipation (15% vs. 4% placebo), hot flush (11% ... that led to early withdrawal among the milnacipran treated patients were nausea (3.5%) and headache and palpitations, each of which occurred at a rate of ...
... (TEMODAR alone), respectively, were alopecia 69%, 55%; fatigue 54%, 61%; nausea 36%, 49%; vomiting 20%, 29%; anorexia 19%, 27%; headache 19%, 23%; ... in the trial in AA patients Grade 3/4 and overall, respectively were: nausea 10%, 53%; vomiting 6%, 42%; headache 6%, 41%; fatigue 4%, 34%; ...
... pill) were constipation (11.0% vs. 7.0%), indigestion (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), accidental injury (3.7% vs. 2.7%), weakness (3.6% vs. ... vs. 3.6%), indigestion (3.9% vs. 1.4%), low blood sugar (3.0% vs. 2.3%), nausea (3.0% vs. 1.4%) and high blood pressure (2.8% vs. 1.6%). You are ...
... safety and tolerability. The compound has the potential to eliminate the nausea that limits the utility of previous PDE4 inhibitors. deCODE plans to ... cilomilast, and roflumilast caused significant side effects, including nausea and vomiting, at the therapeutic doses in human clinical trials. Such side ...
... and/or highly nausea-inducing chemotherapy regimen. Chemotherapy-induced nausea and vomiting (CINV) are commonly cited by patients undergoing chemotherapy ... control was defined as no vomiting and/or retching, no more than mild nausea and no rescue medication from first administration of Sancuso until 24 ...
... alone were stomatitis (44%), rash (40%), diarrhea (37%), fatigue (29%), nausea (26%), vomiting (17%), asthenia (16%), anemia (12%) and weight decrease ... Depot were stomatitis (49%), rash (40%), diarrhea (29%), fatigue (33%), nausea (33%), vomiting (13%), asthenia (11%), anemia (18%) and weight decrease ...
... the following secondary endpoints: sustained headache response, absence of nausea or vomiting, absence of phonophobia and absence of photophobia. "This is ... migraine attacks are frequently accompanied by photophobia, phonophobia, nausea and vomiting. About TorreyPines Therapeutics TorreyPines Therapeutics, ...
... limited to patients using background sulfonylurea therapy. In both groups, nausea was predominantly mild and transient and occurred less frequently in ... to exenatide once weekly did not experience a significant increase in nausea following the transition. The antibody profiles of patients treated in ...
... limited to patients using background sulfonylurea therapy. In both groups, nausea was predominantly mild and transient and occurred less frequently in the ... Twenty-six percent of patients receiving exenatide once weekly reported nausea during the 30-week study. The antibody profiles of patients treated in ...
... (32 percent vs. 16 percent), ALT increase (30 percent vs. 16 percent), nausea (29 percent vs. 16 percent), hypertension (26 percent vs. 4 percent), ... common adverse events (AEs) were diarrhea (81 percent), rash (66 percent), nausea (56 percent), fatigue (56 percent), and vomiting (46 percent). The ...
... acting pain medications have bothersome side effects. These can include nausea and vomiting with short-term use, and constipation with longer, chronic ... While the incidence of nausea, vomiting, constipation and the composite nausea and vomiting were significantly lower in the tapentadol IR treated groups ...
... marked by severe, disabling headaches that are often accompanied by nausea and vomiting. Up to 17 percent of women and 6 percent of men suffer from ... receiving ROX-828 than placebo. Associated migraine symptoms, including nausea and vomiting, also showed statistically significant improvement when ...
... of studied patients. The most common adverse events for Tygacil were nausea (24.3 percent), vomiting (16.0 percent) and abdominal pain (5.7 percent). ... adverse events in patients treated with Tygacil were nausea (29.5 percent) and vomiting (19.7 percent). -- Tygacil may cause ...
... experience gastrointestinal side effects, such as nausea and vomiting. The use of opioid pain medicines ... risk factor for experiencing these side effects. nausea and vomiting are uncomfortable and bothersome and ... orthopedic surgery and significant reduction in nausea and/or vomiting compared to oxycodone IR. ...
... asthenia (40% vs 51%), fever (21% vs 31%), nausea (46% vs 63%), stomatitis (41% vs 15%), ... (31% vs 22%), asthenia (22% vs 18%), nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting ... (<150,000 platelets/mm3, 61%), nausea (18%), asthenia (7%), fever (8%), alopecia ...
... (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting ... (>10%) were rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), ... 4 mg (n=1031) were as follows: bone pain (55%), nausea (46%), fatigue (39%), anemia (33%), pyrexia ...
... vs. 11 percent in the lopinavir/r arm. nausea was reported in two percent vs. three percent, ... headache (5 percent), abdominal pain (4 percent), nausea (3 percent), vomiting (2 percent), and rash (2 ... (> or = Grade 2) were diarrhea (12 percent), nausea (7 percent), abdominal pain (5 percent), rash (6 ...
... hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%) and musculoskeletal ... (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting ... (20.5%) and peripheral edema was not reported. nausea and vomiting were the most commonly reported ...
... no serious adverse events reported. Drug-induced nausea was very low and migraine-associated nausea also decreased with treatment. The Company ... of intravenous DHE while avoiding the nausea that intravenous administration can cause. ...
... Benefits for Patients with Chemotherapy-Induced nausea and Vomiting PHILADELPHIA and LONDON, May 29 ... of patients experiencing chemotherapy-induced nausea and vomiting (CINV). Adding a single oral dose ... CINV can last for about five days and the risk of nausea and vomiting without prophylaxis is greater than ...
QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy
... of Q8003IR. Typical of opioid drugs, nausea and vomiting were the most common adverse events. ... 12mg/8mg dose, 56% experienced mild to moderate nausea that diminished over the first few hours of treatment; no incidences of severe nausea were reported. 32% of patients reported vomiting ...... of nausea. Patients who experience severe nausea should inform their physician. AMITIZA should ... common adverse reactions (incidence > 4%) were nausea (29%), diarrhea (12%), headache (11%), abdominal ... common adverse reactions (incidence > 4%) were nausea (8%), diarrhea (7%), and abdominal pain (5%). ...
Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
... 2:00-6:00 p.m. Abstract No: 9617 induced nausea and Vomiting Location: S Hall ... chemotherapy-induced nausea and vomiting (CINV) ... of chemotherapy-induced nausea and vomiting (CINV) ...GlaxoSmithKline Reports Further Progress of Oncology Portfolio
... 2 pm - 6 pm, S-Hall A1 Chemotherapy-Induced nausea and Vomiting (CINV) Phase III results of a ... oral dosing regimens for chemotherapy-induced nausea and vomiting (CINV) in patients (Pts) ... HYCAMTIN for Injection when used alone included nausea (64%), vomiting (45%), diarrhea (32%), hair loss ...... 3%), fatigue (ABILIFY: 11%; placebo: 4%), nausea (ABILIFY: 11%; placebo: 4%), akathisia (ABILIFY: ... disorder (20% vs 3%), fatigue (11% vs 4%), nausea (11% vs 4%), akathisia (10% vs 2%), blurred ... with agitation associated with bipolar mania: nausea (9% vs 3%) Please see FULL PRESCRIBING ...
MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
... in the prevention and treatment of nausea and vomiting. MonoSol Rx's thin film ... often have difficulty swallowing due to extreme nausea caused by chemotherapy, radiotherapy and surgical ... are the prevention of Chemotherapy-Induced nausea and Vomiting (CINV), ...... diarrhea (14 percent vs. 24 percent), and nausea (15 percent vs. 15 percent). In DUET-2, the ... of any type (16.6 percent vs. 11.1 percent) and nausea (14.6 percent vs. 10.8 percent). Important ... were rash (16.9 percent vs. 9.3 percent) and nausea (13.9 percent vs. 11.1 percent) -- The most ...
Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
... the study. These key secondary measures included nausea or vomiting, photophobia, a sum of pain intensity ... the following: headache response p=0.033; nausea p=0.014; photophobia p=0.056; phonophobia ... accompanied by photophobia, phonophobia, nausea and vomiting. Although once thought to be ...Mayo Clinic Study Finds FDA Warning Against Anti-Nausea Drug Droperidol Unnecessary
... of patients' responses to a drug used to control nausea and vomiting during anesthesia for general ... safer and more effective agent for controlling nausea and vomiting, which is why we are making plans to ... that all drugs used to prevent or control nausea prior to anesthesia use in general surgery also ...The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
... led to a weight reduction of on average 3 kg during the 26-week study. nausea was the most commonly reported adverse event with both treatments but the study results showed that there was less persistent nausea and fewer minor hypoglycemic events with liraglutide compared to ....... mmHg for those with abnormal baselines]. Safety Profile nausea was the most common event during the 30-week treatment period and ... vomiting, diarrhea, dizziness, headache, feeling jittery and acid stomach. nausea is the most common side effect when first starting BYETTA, but decreases ...
... common adverse events in the pirfenidone group as compared to placebo were nausea (35% vs. 18% in CAPACITY 2 and 38% vs. 16% in CAPACITY 1), rash (31% vs. ... to various adverse events were as follows: IPF (2.9/2.6); rash (1.4/0); nausea (1.4/0); bladder cancer (0.9/0); photosensitivity reaction (0.9/0.3); ...
Strativa Pharmaceuticals Provides Product Pipeline Update
... 4 mg strengths for the prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of post-operative nausea and vomiting. A program consisting of three separate pivotal ...... 80% of patients completed the study, and there was one withdrawal due to nausea in each treatment arm. There was no major hypoglycemia in any treatment ... adverse events among exenatide once weekly and sitagliptin users were nausea and diarrhea. Upper respiratory tract infection and peripheral edema were ...
... were asthenic conditions (including fatigue, malaise and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC ... were thrombocytopenia (52% vs 47%), neutropenia (49% vs 46%), nausea (48% vs 28%), peripheral neuropathy (47% vs 5%), diarrhea (46% vs 17%), ...
... reported adverse reactions (>10%) were rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), ... reported adverse reactions (all Grades) were superficial edema (60%-74%), nausea (50%-73%), muscle cramps (28%-62%), vomiting (23%-58%), diarrhea ...
Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
... brain and nervous system(5) and may help some women reduce severe nausea or vomiting during pregnancy(6). It also helps the body maintain blood ... 24, 2008. (6) Sahakian V., et al. Vitamin B6 Is Effective Therapy for nausea and Vomiting of Pregnancy: A Randomized, Double Blind Placebo-Controlled ...... the stable-dose treatment period of the placebo-controlled trial included nausea (37% vs. 21% placebo), constipation (15% vs. 4% placebo), hot flush (11% ... that led to early withdrawal among the milnacipran treated patients were nausea (3.5%) and headache and palpitations, each of which occurred at a rate of ...
... (TEMODAR alone), respectively, were alopecia 69%, 55%; fatigue 54%, 61%; nausea 36%, 49%; vomiting 20%, 29%; anorexia 19%, 27%; headache 19%, 23%; ... in the trial in AA patients Grade 3/4 and overall, respectively were: nausea 10%, 53%; vomiting 6%, 42%; headache 6%, 41%; fatigue 4%, 34%; ...
... pill) were constipation (11.0% vs. 7.0%), indigestion (8.3% vs. 3.5%), nausea (4.2% vs. 3.9%), accidental injury (3.7% vs. 2.7%), weakness (3.6% vs. ... vs. 3.6%), indigestion (3.9% vs. 1.4%), low blood sugar (3.0% vs. 2.3%), nausea (3.0% vs. 1.4%) and high blood pressure (2.8% vs. 1.6%). You are ...
... safety and tolerability. The compound has the potential to eliminate the nausea that limits the utility of previous PDE4 inhibitors. deCODE plans to ... cilomilast, and roflumilast caused significant side effects, including nausea and vomiting, at the therapeutic doses in human clinical trials. Such side ...
... and/or highly nausea-inducing chemotherapy regimen. Chemotherapy-induced nausea and vomiting (CINV) are commonly cited by patients undergoing chemotherapy ... control was defined as no vomiting and/or retching, no more than mild nausea and no rescue medication from first administration of Sancuso until 24 ...
... alone were stomatitis (44%), rash (40%), diarrhea (37%), fatigue (29%), nausea (26%), vomiting (17%), asthenia (16%), anemia (12%) and weight decrease ... Depot were stomatitis (49%), rash (40%), diarrhea (29%), fatigue (33%), nausea (33%), vomiting (13%), asthenia (11%), anemia (18%) and weight decrease ...
... the following secondary endpoints: sustained headache response, absence of nausea or vomiting, absence of phonophobia and absence of photophobia. "This is ... migraine attacks are frequently accompanied by photophobia, phonophobia, nausea and vomiting. About TorreyPines Therapeutics TorreyPines Therapeutics, ...
... limited to patients using background sulfonylurea therapy. In both groups, nausea was predominantly mild and transient and occurred less frequently in ... to exenatide once weekly did not experience a significant increase in nausea following the transition. The antibody profiles of patients treated in ...
... limited to patients using background sulfonylurea therapy. In both groups, nausea was predominantly mild and transient and occurred less frequently in the ... Twenty-six percent of patients receiving exenatide once weekly reported nausea during the 30-week study. The antibody profiles of patients treated in ...
... (32 percent vs. 16 percent), ALT increase (30 percent vs. 16 percent), nausea (29 percent vs. 16 percent), hypertension (26 percent vs. 4 percent), ... common adverse events (AEs) were diarrhea (81 percent), rash (66 percent), nausea (56 percent), fatigue (56 percent), and vomiting (46 percent). The ...
... acting pain medications have bothersome side effects. These can include nausea and vomiting with short-term use, and constipation with longer, chronic ... While the incidence of nausea, vomiting, constipation and the composite nausea and vomiting were significantly lower in the tapentadol IR treated groups ...
... marked by severe, disabling headaches that are often accompanied by nausea and vomiting. Up to 17 percent of women and 6 percent of men suffer from ... receiving ROX-828 than placebo. Associated migraine symptoms, including nausea and vomiting, also showed statistically significant improvement when ...
Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
... fatigue (36% vs 28%), pyrexia (31% vs 22%), asthenia (22% vs 18%), nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting (32% vs 22%), ... the most commonly reported adverse events were asthenic conditions (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy (39%), ...Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
... (cethromycin 4.5%, Biaxin 4.1%), headache (cethromycin 2.4%, Biaxin 3.1%), nausea (cethromycin 4.5%, Biaxin 1.4%), vomiting (cethromycin 1.4%, Biaxin 1.0%), ... (7/288) (9/291) (8/260) (16/257) (15/548) (25/548) nausea 4.5% 1.4% 2.7% 3.9% 3.6% 2.6% ...... of studied patients. The most common adverse events for Tygacil were nausea (24.3 percent), vomiting (16.0 percent) and abdominal pain (5.7 percent). ... adverse events in patients treated with Tygacil were nausea (29.5 percent) and vomiting (19.7 percent). -- Tygacil may cause ...
Other ContentscarcarcarcarcarcarbunclecarcinoidarrestarrestarrestarrestarrestarrestcatheterizationcatheterizationcatheterizationcatheterizationcatheterizationcatheterizationcardiogeniccardiogeniccardiologycardiologycardiologycardiologycardiologytamponadeOther TagsSynchron
(Date:11/26/2009)...d for their impressive antlers, red deer have been...t a deer,s antlers are much more than decorative. ...when duelling. John Currey, from The University of...operties of bone for over half a century and has b...ntler through a long-standing collaboration with T...
(Date:11/26/2009)...(methicillin-resistant Staphylococcus Aureus ) an...ation as low-temperature plasma prototype devices ... unfailing bactericidal cocktails. , Two prototy...disinfection of healthy skin (e.g. hands and feet)... pose a lethal threat; and another to shoot bacter...
(Date:11/25/2009)... Sarit Larisch, Head of the Cell Death Research La...f Biology, has been awarded the prestigious Johnso... exploring the cause of brain cell damage in Parki...ear to scientists in support of innovation and exc...icially conferred earlier this month at an event a...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 1Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 2Daisy Brand 28R 29 Cottage Cheese Invites Americans to Freshen Up Your Fridge 48485 3Studies Report More Harmful Effects From BPA 48481 1Studies Report More Harmful Effects From BPA 48481 2Studies Report More Harmful Effects From BPA 48481 3Zero tolerance alcohol policy good choice for parents 48478 1Zero tolerance alcohol policy good choice for parents 48478 2(Date:11/30/2009)... , TORONTO, Nov. 30 /PRNewswire-FirstCall/ - A...V - AHG), a fully integrated health care company, ...month period ended September 30, 2009 (the "Quarte... period in 2008. At the same time EBITDA(1) increa...ver-quarter basis. The Company also announced that...
(Date:11/30/2009)... , MOBILE, Ala., Nov. 30 Mary ...y Affairs for The SSI Group, Inc., (SSI) has been ...ectronic Data Interchange (WEDI). ,, Hyland ha...nce joining the organization in 2001. She was init...of the Quality Assurance division and Business Con...
(Date:11/30/2009)... , IRVINE, Calif., Nov. 30 A r...ists, referring physicians, and patients with seam...ports with just the click of a button was announce...ing providers of image management, visualization a...ng workflow and doing away with the cumbersome and...
(Date:11/30/2009)... , DALLAS, Nov. 30 I,m surprise... case this week. At every step of my life and my ...as the Independent Ombudsman for the Texas Youth C... of the law. My professional commitment to the pr...ldren is also my personal passion. ,, Of the ...
(Date:11/30/2009)...ion leaves them without treatment for blood-borne ...v. 30 (HealthDay News) -- Many medical students ge...-borne diseases, but they often fail to alert hosp...fection, a new study has found. , The researche... centers and found that 415 -- 59 percent -- had e...
Breaking Medicine News(10 mins):Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:SSI Assistant Vice President Elected to WEDI Board 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 3Health News:Independent Ombudsman for Texas Youth Commission Resigns 2Health News:Med Students Often Fail to Report Needlestick Injuries 2VersatrekCogentRiboprinterFinstrumentsCellwashFinstripMicrotechMultiWashSynchronMetrikaMicromatCascadeElectraHemoSite
Other Tagscondom 2condom 3condom 4condom 5condom 6condom 7tools 2tools 3tools 4tools 5tools 6tools 7tools 8tools 9tools 10properly 2properly 3properly 4properly 5properly 6properly 7properly 8properly 9properly 10coma 2malfunctioning 2traditional 2traditional 3traditional 4traditional 5traditional 6traditional 7traditional 8traditional 9traditional 10settings 2settings 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |